| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |